Why is the UK trying to delete all mentions of high drug prices at the World Health Assembly?


21 May 2019

This week in Geneva a resolution is being voted on which could help make drugs more affordable around the world. 

Yet we’ve discovered that the UK government is trying to undermine the resolution at this week's World Health Assembly – and is even pushing for all references to “high prices” to be taken out. This is an outrage.

High prices are a big reason why people are not getting the essential medicines they need, in the UK and around the world. Denying that they exist is not an option. The UK should be backing, not blocking, this global effort to make medicines more affordable. 

A global crisis

There is a global crisis of high medicine prices. We're seeing it in the news more and more, with patients unable to access vital drugs like Orkambi, which could be lifesaving for people with cystic fibrosis. And this is even more serious for people in the global south. 

High drug prices also impact on healthcare services like the NHS which is already rationing and rejecting effective new drugs because they are too expensive.

Corporate secrecy

This week’s resolution on drug pricing transparency is supported by Italy, Malaysia and South Africa, along with seven other countries. The aim is to remove much of the corporate secrecy over drug prices, research and development costs, and public contributions to drug development.

Having this information would radically improve the negotiating position of governments in price negotiations with big pharmaceutical companies. And this is part of our vision for a health system that works for all, not just corporations. But rich countries, including the UK, are piling in and making changes to the wording of the resolution to water it down and make it voluntary.

Exposing this latest UK government capitulation to the pharmaceutical industry’s lobbying is part of our People’s Prescription campaign. Together, we’re pushing the issue of drug pricing up the political agenda, and promoting proposals for overhauling our current corporate-controlled system of drug research and development that can make a real difference to millions of people around the world.

Take action

We're asking the health secretary, Matthew Hancock, and the international development secretary, Rory Stewart, why the UK government is in denial about this global problem.

Can you tweet at them some recent headlines about #HighDrugPrices?

Blog

Here’s what a trade deal with Trump could mean for our NHS


07 June 2019

This week the unacceptably high price of trading with Trump was laid bare as he declared that the NHS would be ‘on the table’ for a future trade deal. He then tried to retreat following a widespread backlash telling another interviewer: ‘I don’t see it being on the table’. Regardless of Trump’s confusion on this, the dangers of a potential US trade deal still are very real.

Brexit trade delusions show why Britain needs to confront its history of empire

The chance for Britain to resume its glorious role as a proud trading nation is one of the defining myths of Brexit. It obscures the reality of ‘free’ trade as an enabling tool of empire, a shameful history which Britain has never truly confronted,

The UK government has blatantly chosen to side with big pharma over patients


28 May 2019

The UK government has recklessly blocked global efforts to tackle big pharma secrecy this week in Geneva. But across the world, people are mobilising to give a strong message that it’s time governments put people over the power of big pharma.